Portrazza Approved for Advanced Lung Cancer

TUESDAY, Nov. 24, 2015 — Portrazza (necitumumab), in combination with two other chemotherapy drugs, has been approved by the U.S. Food and Drug Administration to treat advanced squamous non-small cell lung cancer, the agency said Tuesday in a news…
Source: Topamax